C/M CAPITAL PARTNERS, LP

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

C/M CAPITAL PARTNERS, LP sits at the top of its group. 9 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (8 companies); owners and owned firms from Form ADV, the registration investment advisers file with the SEC. Each entity in the chart links to its source.

Investment adviser

C/M CAPITAL PARTNERS, LP is registered with the SEC as an investment adviser. This is what it reports on Form ADV, the registration every adviser files and keeps current.

• RegistrationSEC 802-131199, CRD 332641 IAPD record

Who owns it

Owners of 5% or more as the firm lists them (Schedule A), and the owners of those owners up the chain (Schedule B).

• Jonathan Thaddeus Juchnoowns 50% to 75%, since 02/2024
• Thomas Pisano Walshowns 50% to 75%, since 02/2024
• Jonathan Thaddeus Juchnoowns 50% to 75% of C/M CAPITAL, since 02/2024
• Thomas Pisano Walshowns 50% to 75% of C/M CAPITAL, since 02/2024

Stakes it holds

C/M CAPITAL PARTNERS, LP has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).

• Flyte Aviation, Inc.SCHEDULE 13G Feb 13, 2026 to Aug 21, 2026³
• Volato Group, Inc.SCHEDULE 13G Jul 6, 2026⁴
• Beeline Holdings, Inc.SCHEDULE 13G Jun 4, 2026⁵
• AUDDIA INC.SCHEDULE 13G/A Aug 7, 2025 to Nov 14, 2025⁶
• Biodexa Pharmaceuticals PlcSCHEDULE 13G/A Feb 18, 2025 to Nov 14, 2025⁷
• Forward Industries, Inc.SCHEDULE 13G/A Jul 28, 2025 to Nov 14, 2025⁸
• IP STRATEGY HOLDINGS, INC.SCHEDULE 13G/A Jul 31, 2025 to Nov 14, 2025⁹
• Decoy Therapeutics Inc.SCHEDULE 13G Oct 14, 2025¹⁰